Condition: Keratoconus, Unstable · Bacterial Keratitis · Ectasia of Cornea · Sponsor: Pacific Clear Vision Institute
To determine whether the Peschke PXL-330 system is safe and effective in the treatment of corneal thinning conditions.
This description comes directly from the study's public registry record.
BALAMURALI AMBATI, MD, PhD · 541-343-5000 · bambati@pcvi.com
Always discuss trial participation with your own doctor first.
| Pacific Clear Vision Institute | Eugene, Oregon, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03918408